Page last updated: 2024-08-23

amonafide and Stomach Neoplasms

amonafide has been researched along with Stomach Neoplasms in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Appella, DH; Chen, Z; Huang, S; Liu, Y; Lou, G; Norton, JT; Wang, C; Witschi, MA; Xu, Q	1
Bauman, A; Benson, AB; Blough, RR; Carroll, RB; French, SL; Kilton, LJ; Mullane, MR; Schilsky, RL; Wade, JL	1

Trials

1 trial(s) available for amonafide and Stomach Neoplasms

Article	Year
Phase II study of amonafide in gastric adenocarcinoma. An Illinois Cancer Center trial. Investigational new drugs, 1994, Volume: 12, Issue:3 Topics: Adenine; Adenocarcinoma; Antineoplastic Agents; Female; Hematologic Diseases; Humans; Imides; Isoquinolines; Male; Naphthalimides; Organophosphonates; Stomach Neoplasms	1994

Other Studies

1 other study(ies) available for amonafide and Stomach Neoplasms

Article	Year
Methoxyethylamino-numonafide is an efficacious and minimally toxic amonafide derivative in murine models of human cancer. Neoplasia (New York, N.Y.), 2011, Volume: 13, Issue:5 Topics: Adenine; Animals; Antineoplastic Agents; Cell Line; Disease Models, Animal; Gene Expression Profiling; Humans; Liver Neoplasms, Experimental; Mice; Mice, Nude; Naphthalimides; Organophosphonates; Stomach Neoplasms; Transplantation, Heterologous	2011

Article

Year

Methoxyethylamino-numonafide is an efficacious and minimally toxic amonafide derivative in murine models of human cancer.

Neoplasia (New York, N.Y.), 2011, Volume: 13, Issue:5

Topics: Adenine; Animals; Antineoplastic Agents; Cell Line; Disease Models, Animal; Gene Expression Profiling; Humans; Liver Neoplasms, Experimental; Mice; Mice, Nude; Naphthalimides; Organophosphonates; Stomach Neoplasms; Transplantation, Heterologous

2011